CSTL logo

Castle Biosciences (CSTL) EBIT

CSTL Annual EBIT

-$57.35 M
+$11.53 M+16.74%

31 December 2023

CSTL EBIT Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

CSTL Quarterly EBIT

$8.48 M
+$327.00 K+4.01%

30 September 2024

CSTL Quarterly EBIT Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

CSTL TTM EBIT

$11.63 M
+$15.35 M+411.75%

30 September 2024

CSTL TTM EBIT Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

CSTL EBIT Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+16.7%+434.1%+120.3%
3 y3 years-658.0%+434.1%+120.3%
5 y5 years-1304.4%+434.1%+120.3%

CSTL EBIT High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-43.4%+16.7%at high+129.1%at high+113.1%
5 y5-year-678.2%+16.7%at high+129.1%at high+113.1%
alltimeall time-678.2%+16.7%at high+129.1%at high+113.1%

Castle Biosciences EBIT History

DateAnnualQuarterlyTTM
Sept 2024
-
$8.48 M(+4.0%)
$11.63 M(-411.7%)
June 2024
-
$8.16 M(-429.5%)
-$3.73 M(-87.8%)
Mar 2024
-
-$2.48 M(-2.5%)
-$30.64 M(-46.6%)
Dec 2023
-$57.35 M(-16.7%)
-$2.54 M(-63.0%)
-$57.35 M(-23.9%)
Sept 2023
-
-$6.87 M(-63.4%)
-$75.37 M(-15.1%)
June 2023
-
-$18.76 M(-35.7%)
-$88.74 M(+20.6%)
Mar 2023
-
-$29.19 M(+42.0%)
-$73.59 M(+6.8%)
Dec 2022
-$68.89 M(+72.2%)
-$20.56 M(+1.6%)
-$68.89 M(+8.5%)
Sept 2022
-
-$20.24 M(+462.1%)
-$63.48 M(+15.4%)
June 2022
-
-$3.60 M(-85.3%)
-$55.03 M(-8.6%)
Mar 2022
-
-$24.49 M(+61.6%)
-$60.22 M(+50.5%)
Dec 2021
-$40.01 M
-$15.15 M(+28.5%)
-$40.01 M(+36.7%)
Sept 2021
-
-$11.79 M(+34.2%)
-$29.27 M(+37.0%)
June 2021
-
-$8.79 M(+105.3%)
-$21.36 M(+62.1%)
DateAnnualQuarterlyTTM
Mar 2021
-
-$4.28 M(-2.9%)
-$13.18 M(+74.2%)
Dec 2020
-$7.57 M(-176.3%)
-$4.41 M(+13.6%)
-$7.57 M(+2776.8%)
Sept 2020
-
-$3.88 M(+539.7%)
-$263.00 K(-102.5%)
June 2020
-
-$607.00 K(-145.5%)
$10.56 M(-8.9%)
Mar 2020
-
$1.33 M(-53.9%)
$11.59 M(+16.8%)
Dec 2019
$9.92 M(-342.9%)
$2.89 M(-58.3%)
$9.92 M(-14.1%)
Sept 2019
-
$6.94 M(+1536.1%)
$11.55 M(+565.5%)
June 2019
-
$424.00 K(-226.9%)
$1.74 M(-231.8%)
Mar 2019
-
-$334.00 K(-107.4%)
-$1.32 M(-67.7%)
Dec 2018
-$4.08 M(-61.9%)
$4.53 M(-257.1%)
-$4.08 M(-52.6%)
Sept 2018
-
-$2.88 M(+9.6%)
-$8.61 M(+50.3%)
June 2018
-
-$2.63 M(-15.2%)
-$5.73 M(+84.8%)
Mar 2018
-
-$3.10 M
-$3.10 M
Dec 2017
-$10.71 M
-
-

FAQ

  • What is Castle Biosciences annual earnings before interest & taxes?
  • What is the all time high annual EBIT for Castle Biosciences?
  • What is Castle Biosciences annual EBIT year-on-year change?
  • What is Castle Biosciences quarterly earnings before interest & taxes?
  • What is the all time high quarterly EBIT for Castle Biosciences?
  • What is Castle Biosciences quarterly EBIT year-on-year change?
  • What is Castle Biosciences TTM earnings before interest & taxes?
  • What is the all time high TTM EBIT for Castle Biosciences?
  • What is Castle Biosciences TTM EBIT year-on-year change?

What is Castle Biosciences annual earnings before interest & taxes?

The current annual EBIT of CSTL is -$57.35 M

What is the all time high annual EBIT for Castle Biosciences?

Castle Biosciences all-time high annual earnings before interest & taxes is $10.28 M

What is Castle Biosciences annual EBIT year-on-year change?

Over the past year, CSTL annual earnings before interest & taxes has changed by +$11.53 M (+16.74%)

What is Castle Biosciences quarterly earnings before interest & taxes?

The current quarterly EBIT of CSTL is $8.48 M

What is the all time high quarterly EBIT for Castle Biosciences?

Castle Biosciences all-time high quarterly earnings before interest & taxes is $8.48 M

What is Castle Biosciences quarterly EBIT year-on-year change?

Over the past year, CSTL quarterly earnings before interest & taxes has changed by +$11.02 M (+434.11%)

What is Castle Biosciences TTM earnings before interest & taxes?

The current TTM EBIT of CSTL is $11.63 M

What is the all time high TTM EBIT for Castle Biosciences?

Castle Biosciences all-time high TTM earnings before interest & taxes is $11.63 M

What is Castle Biosciences TTM EBIT year-on-year change?

Over the past year, CSTL TTM earnings before interest & taxes has changed by +$68.98 M (+120.27%)